SLEEP NUMBER CORP (SNBR)

US83125X1037 - Common Stock

11.67  -0.1 (-0.85%)

After market: 11.67 0 (0%)

Fundamental Rating

2

SNBR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. While SNBR is still in line with the averages on profitability rating, there are concerns on its financial health. SNBR has a expensive valuation and it also scores bad on growth.



Quickly go to:

4

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
In the past year SNBR had a positive cash flow from operations.
Of the past 5 years SNBR 4 years were profitable.
Of the past 5 years SNBR 4 years had a positive operating cash flow.

1.2 Ratios

SNBR's Return On Assets of -4.73% is on the low side compared to the rest of the industry. SNBR is outperformed by 64.46% of its industry peers.
SNBR's Return On Invested Capital of 4.70% is in line compared to the rest of the industry. SNBR outperforms 55.37% of its industry peers.
SNBR had an Average Return On Invested Capital over the past 3 years of 17.46%. This is significantly above the industry average of 12.26%.
The last Return On Invested Capital (4.70%) for SNBR is well below the 3 year average (17.46%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -4.73%
ROE N/A
ROIC 4.7%
ROA(3y)6.31%
ROA(5y)9.3%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.46%
ROIC(5y)21.4%

1.3 Margins

Looking at the Operating Margin, with a value of 1.76%, SNBR is in line with its industry, outperforming 50.41% of the companies in the same industry.
SNBR's Operating Margin has declined in the last couple of years.
SNBR's Gross Margin of 58.80% is amongst the best of the industry. SNBR outperforms 88.43% of its industry peers.
SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.76%
PM (TTM) N/A
GM 58.8%
OM growth 3Y-40.97%
OM growth 5Y-19.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-0.98%

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SNBR is creating value.
The number of shares outstanding for SNBR has been increased compared to 1 year ago.
SNBR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNBR has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.47, we must say that SNBR is in the distress zone and has some risk of bankruptcy.
SNBR has a Altman-Z score of 0.47. This is amonst the worse of the industry: SNBR underperforms 80.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.47
ROIC/WACC0.5
WACC9.48%

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR's Current ratio of 0.19 is on the low side compared to the rest of the industry. SNBR is outperformed by 99.17% of its industry peers.
A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
SNBR's Quick ratio of 0.09 is on the low side compared to the rest of the industry. SNBR is outperformed by 97.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SNBR have decreased strongly by -1005.00% in the last year.
Looking at the last year, SNBR shows a very negative growth in Revenue. The Revenue has decreased by -11.27% in the last year.
SNBR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.27% yearly.
EPS 1Y (TTM)-1005%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-11.27%
Revenue growth 3Y0.55%
Revenue growth 5Y4.27%
Sales Q2Q%-9.74%

3.2 Future

The Earnings Per Share is expected to grow by 41.51% on average over the next years. This is a very strong growth
SNBR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.11% yearly.
EPS Next Y-38.75%
EPS Next 2Y59.66%
EPS Next 3Y50.74%
EPS Next 5Y41.51%
Revenue Next Year-9.76%
Revenue Next 2Y-4.21%
Revenue Next 3Y-1.84%
Revenue Next 5Y1.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 31.26, the valuation of SNBR can be described as expensive.
SNBR's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of SNBR to the average of the S&P500 Index (23.56), we can say SNBR is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 31.26

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 99.17% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.6

4.3 Compensation for Growth

A more expensive valuation may be justified as SNBR's earnings are expected to grow with 50.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.66%
EPS Next 3Y50.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLEEP NUMBER CORP

NASDAQ:SNBR (11/20/2024, 8:00:02 PM)

After market: 11.67 0 (0%)

11.67

-0.1 (-0.85%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap261.06M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.26
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.73%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 1.76%
PM (TTM) N/A
GM 58.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1005%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-38.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.27%
Revenue growth 3Y0.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y